John Kersten Kraft, M D
Urology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call John Kersten Kraft’s office at (408) 358-2030 to ask if they take your plan before you enroll.
California Medical Board record
Licence G23536 · Current
Licensed to practise in California · since 1972 · expires 2028-06-30 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$4,773
Medicare paid this office $4,773 for 19 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Who their Medicare patients are
19 Original Medicare patients in 2024. Average age 80 · Health risk score 2.22. Sicker patients than 9 in 10 peers; the typical urology clinician is at 1.36.
Conditions among them: High blood pressure 75% · Chronic kidney disease 58%.
The office billed $22,276, Medicare allowed $5,991 and paid $4,773; for 43 services of 11 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 19 | 43 | 80 | 2.22 | $22,276 | $4,773 |
| 2022 | 178 | 4,855 | 79 | 1.09 | $99,648 | $32,421 |
| 2021 | 236 | 5,997 | 78 | 1.04 | $140,090 | $44,776 |
| 2020 | 315 | 10,361 | 78 | 1.18 | $238,910 | $82,415 |
| 2019 | 481 | 18,116 | 78 | 1.26 | $558,618 | $201,871 |
| 2018 | 470 | 18,356 | 77 | 1.16 | $556,339 | $193,507 |
| 2017 | 518 | 16,570 | 77 | 1.11 | $551,663 | $186,822 |
| 2016 | 551 | 14,245 | 77 | 1.12 | $481,148 | $152,717 |
| 2015 | 621 | 16,077 | 77 | 1.12 | $522,225 | $168,728 |
| 2014 | 641 | 3,131 | 76 | 1.03 | $540,446 | $182,224 |
| 2013 | 651 | 2,439 | 76 | 1.06 | $613,129 | $213,825 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2022: 3 services
| Short return visit (20+ min) | 123 | $10,452 | $68 |
| Return visit (30+ min) | 52 | $6,403 | $105 |
| Ultrasound measurement of bladder capacity after voiding | 103 | $1,271 | $10 |
2021: 4 services
| Short return visit (20+ min) | 208 | $20,005 | $73 |
| Return visit (30+ min) | 21 | $2,506 | $104 |
| Ultrasound measurement of bladder capacity after voiding | 96 | $995 | $10 |
| Manual urinalysis test with examination using microscope, non-automated | 26 | $105 | $4 |
2020: 7 services
| Short return visit (20+ min) | 248 | $21,635 | $63 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 12 | $14,605 | None |
| Return visit (30+ min) | 58 | $5,200 | $79 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $3,569 | $89 |
| Ultrasound measurement of bladder capacity after voiding | 183 | $1,967 | $9 |
| New patient visit (45+ min) | 12 | $1,083 | $90 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 12 | $626 | $30 |
2019: 15 services
| Short return visit (20+ min) | 323 | $30,739 | $63 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 18 | $28,543 | None |
| Return visit (30+ min) | 134 | $14,584 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 42 | $8,533 | $86 |
| Ultrasound measurement of bladder capacity after voiding | 386 | $7,156 | $12 |
| New patient visit (45+ min) | 53 | $7,037 | $133 |
| Critical care, first 30-74 minutes | 11 | $4,309 | $196 |
| Diagnostic exam of bladder and urethra using an endoscope | 14 | $4,190 | $182 |
| Complete ultrasound scan behind abdominal cavity | 16 | $1,904 | $100 |
| Long return visit (40+ min) | 15 | $1,508 | $101 |
| Complete ultrasound scan of pelvis | 16 | $1,328 | $78 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 18 | $1,172 | $29 |
| Injection of drug or substance under skin or into muscle | 14 | $1,037 | $16 |
| Manual urinalysis test with examination using microscope, non-automated | 182 | $890 | $4 |
| Automated urinalysis test | 186 | $549 | $2 |
2018: 14 services
| Short return visit (20+ min) | 292 | $29,897 | $63 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 15 | $20,580 | None |
| Return visit (30+ min) | 162 | $19,214 | $92 |
| Ultrasound measurement of bladder capacity after voiding | 410 | $10,889 | $16 |
| New patient visit (45+ min) | 72 | $10,198 | $142 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 36 | $7,793 | $93 |
| Complicated insertion of bladder tube | 18 | $4,045 | $116 |
| Critical care, first 30-74 minutes | 11 | $3,972 | $189 |
| Diagnostic exam of bladder and urethra using an endoscope | 18 | $3,453 | $164 |
| Complete ultrasound scan behind abdominal cavity | 17 | $2,057 | $114 |
| Automated urinalysis test | 402 | $1,778 | $3 |
| Complete ultrasound scan of pelvis | 16 | $1,287 | $76 |
| Injection of drug or substance under skin or into muscle | 13 | $1,256 | $20 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 15 | $1,122 | $31 |
2017: 14 services
| Short return visit (20+ min) | 364 | $36,907 | $63 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 20 | $26,955 | None |
| Return visit (30+ min) | 143 | $14,512 | $90 |
| Ultrasound measurement of bladder capacity after voiding | 448 | $12,482 | $19 |
| New patient visit (45+ min) | 60 | $8,561 | $143 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 35 | $8,150 | $92 |
| Diagnostic exam of bladder and urethra using an endoscope | 21 | $4,285 | $159 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,791 | $164 |
| Complete ultrasound scan behind abdominal cavity | 17 | $2,063 | $109 |
| Automated urinalysis test | 449 | $2,055 | $3 |
| Long return visit (40+ min) | 14 | $1,895 | $126 |
| New patient visit (30+ min) | 21 | $1,766 | $84 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 20 | $1,531 | $31 |
| Complete ultrasound scan of pelvis | 14 | $1,127 | $75 |
2016: 14 services
| Short return visit (20+ min) | 394 | $36,764 | $59 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 20 | $26,854 | None |
| Return visit (30+ min) | 140 | $13,183 | $85 |
| New patient visit (45+ min) | 50 | $6,744 | $135 |
| Ultrasound measurement of bladder capacity after voiding | 241 | $5,492 | $19 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 29 | $5,163 | $88 |
| Diagnostic exam of bladder and urethra using an endoscope | 18 | $4,098 | $186 |
| Biopsy of prostate gland | 16 | $3,121 | $195 |
| New patient visit (30+ min) | 28 | $2,193 | $78 |
| Automated urinalysis test | 449 | $2,038 | $3 |
| Complete ultrasound scan behind abdominal cavity | 16 | $1,715 | $107 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 20 | $1,080 | $28 |
| Ultrasonic guidance for needle placement | 16 | $819 | $51 |
| Limited ultrasound scan of pelvis | 11 | $445 | $40 |
2015: 18 services
| Short return visit (20+ min) | 477 | $45,721 | $61 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 16 | $21,899 | None |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 18 | $13,578 | $754 |
| Return visit (30+ min) | 89 | $8,417 | $89 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 14 | $6,981 | $499 |
| New patient visit (45+ min) | 48 | $6,364 | $133 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 28 | $5,335 | $89 |
| New patient visit (30+ min) | 52 | $5,083 | $98 |
| Diagnostic exam of bladder and urethra using an endoscope | 18 | $5,068 | $188 |
| Biopsy of prostate gland | 15 | $3,290 | $206 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $3,047 | $179 |
| Automated urinalysis test | 501 | $2,193 | $3 |
| Complete ultrasound scan behind abdominal cavity | 14 | $1,424 | $95 |
| Complete ultrasound scan of pelvis | 17 | $1,217 | $68 |
| Ultrasound scan of pelvic region through rectum | 11 | $1,118 | $93 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 15 | $975 | $30 |
| Ultrasonic guidance for needle placement | 15 | $922 | $58 |
| Ultrasound measurement of bladder capacity after voiding | 11 | $255 | $18 |
2014: 18 services
| Short return visit (20+ min) | 485 | $48,712 | $61 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 18 | $21,565 | None |
| Return visit (30+ min) | 123 | $12,954 | $96 |
| New patient visit (45+ min) | 66 | $9,289 | $141 |
| Diagnostic exam of bladder and urethra using an endoscope | 25 | $6,105 | $174 |
| Ultrasound measurement of bladder capacity after voiding | 185 | $4,689 | $19 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 21 | $4,317 | $180 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $3,974 | $92 |
| Complete ultrasound scan behind abdominal cavity | 28 | $3,643 | $130 |
| Automated urinalysis test | 556 | $2,900 | $3 |
| Complete ultrasound scan of pelvis | 21 | $1,947 | $88 |
| New patient visit (30+ min) | 18 | $1,656 | $92 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 47 | $1,492 | $19 |
| Injection of drug or substance under skin or into muscle | 14 | $1,484 | $24 |
| Ultrasound scan of pelvic region through rectum | 13 | $1,480 | $92 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 18 | $1,149 | $31 |
| Ultrasonic guidance for needle placement | 12 | $1,033 | $69 |
| Short return visit | 20 | $830 | $38 |
2013: 20 services
| Short return visit (20+ min) | 521 | $51,650 | $61 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 24 | $25,901 | None |
| New patient visit (45+ min) | 90 | $12,531 | $139 |
| Return visit (30+ min) | 89 | $8,268 | $89 |
| Ultrasonic guidance for needle placement | 31 | $7,303 | $209 |
| Diagnostic exam of bladder and urethra using an endoscope | 29 | $6,863 | $191 |
| Ultrasound of abdomen and pelvis artery and vein blood flow | 31 | $6,479 | $209 |
| Complete ultrasound scan behind abdominal cavity | 42 | $6,119 | $130 |
| Biopsy of prostate gland | 29 | $5,662 | $195 |
| Complicated insertion of bladder tube | 14 | $4,074 | $113 |
| Complete ultrasound scan of pelvis | 37 | $3,282 | $84 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 78 | $3,217 | $19 |
| Ultrasound measurement of bladder capacity after voiding | 107 | $2,994 | $19 |
| Ultrasound scan of pelvic region through rectum | 35 | $2,738 | $70 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 24 | $1,443 | $33 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $1,347 | $90 |
| Injection of drug or substance under skin or into muscle | 13 | $1,329 | $24 |
| New patient visit (30+ min) | 12 | $1,040 | $87 |
| Short return visit | 17 | $631 | $37 |
| Automated urinalysis test | 93 | $336 | $3 |
Money from drug and device companies
$53 in 2022
| 2022 | 1 | 2 | None | $53 |
| 2021 | 1 | 3 | None | $79 |
| 2020 | 2 | 9 | None | $236 |
| 2019 | 5 | 10 | None | $328 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Lupron Depot | $53 | 2 payments
|
See all 2 published payments
| Abbvie | Meals · 2022-04-02 | Lupron Depot | $26 |
| Abbvie | Meals · 2022-02-08 | Lupron Depot | $26 |
See earlier years (2021, 2020, 2019)
2021: $79
| AbbVie | Lupron Depot | $79 | 3 payments
|
2020: $236
| AbbVie | Lupron Depot | $120 | 7 payments
|
| Amgen | Prolia | $116 | 2 payments
|
2019: $328
| Pfizer | Xtandi | $125 | 1 payment
|
| AbbVie | Lupron Depot | $66 | 3 payments
|
| Amgen | Prolia | $64 | 2 payments
|
| Janssen Biotech | Erleada | $50 | 3 payments
|
| Bayer HealthCare Pharmaceuticals | Nubeqa | $23 | 1 payment
|
Professional record
- NPI
- 1679646533
- Licence
- CA G23536California G23536: Current · expires 2028-06-30
More record details
- Sole proprietor
- No
- Taxonomy
- Urology (208800000X)
- Mailing address
- 2581 Samaritan Drive, Suite 200, San Jose, CA, 95124
- NPI first listed
- 2006-11-16
- NPI last updated
- 2007-07-08
This is when the NPI record was last certified, not a medical board exam.